Compare RGNX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGNX | THFF |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 940.1M |
| IPO Year | 2015 | 1995 |
| Metric | RGNX | THFF |
|---|---|---|
| Price | $9.63 | $79.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | $28.75 | ★ $62.00 |
| AVG Volume (30 Days) | ★ 1.2M | 76.6K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | 18.08 | ★ 67.00 |
| EPS | N/A | ★ 3.58 |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $51.21 | $17.88 |
| Revenue Next Year | $19.08 | $4.03 |
| P/E Ratio | ★ N/A | $22.21 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $51.21 |
| 52 Week High | $16.19 | $84.17 |
| Indicator | RGNX | THFF |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 50.17 |
| Support Level | $9.34 | $77.91 |
| Resistance Level | $9.67 | $84.00 |
| Average True Range (ATR) | 0.71 | 1.67 |
| MACD | -0.18 | -0.41 |
| Stochastic Oscillator | 38.98 | 26.36 |
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.